Jay Yadav
InvestorVenture Capital Investment Decision Maker at Mammoth Research
About
Dr. Jay Yadav is an investment decision maker at Mammoth Research and a medical device entrepreneur focused on treatments for cardiovascular and neurological conditions. He founded CardioMEMS (heart failure), Angioguard (stroke; acquired by Johnson & Johnson), and MiRus, and was the first investor and a director of SMART Therapeutics. He has extensive experience navigating FDA and CMS regulatory and reimbursement pathways, has authored over 300 peer-reviewed publications, 2 books, and more than 40 patents, and currently serves as CEO of MiRus, LLC.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Investments
Board seats
SMART Therapeutics
Investor
Angioguard, Inc.CardioMEMSMiRus
Per the firm's website.
Colleagues at Mammoth Research
Erin Heck
General Partner at Mammoth Research
Jacob Cook
VP of Finance and Business Development at Mammoth Research
Jessi Robbins
Investor Relations at Mammoth Research
Jud Mackrill
General Partner at Mammoth Research
Kimberly Mackrill
General Partner at Mammoth Research
Matthew McGirt
General Partner at Mammoth Research
Shiraz Javed
Global Investor Relations at Mammoth Research
Tommy Martin
General Partner at Mammoth Research
Frequently asked questions
- Where does Jay Yadav work?
- Jay Yadav is Venture Capital Investment Decision Maker at Mammoth Research.
- What does Jay Yadav invest in?
- Jay Yadav invests in Biotech, Digital Health, Healthtech, Medical Devices.